The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells
DOI: 10.1016/j.biomaterials.2014.01.037
Authors: Sophia Zhang; James R. Dutton; Liping Su; Jianyi Zhang; Lei Ye
Step 1: iPSC/ESC maintainance
day 0 ~ 2
culture “spheroid” human PSC in “unspecified medium” for “2” days. “PSC” should be “upregulated” for “GFP”. For ECM, use “fibrin” at “N/A” “N/A”. Medium should be changed once in “2” days.
Step 2: mesoderm 1
day 2 ~ 3
culture “spheroid” human PSC in “EBM2” for “1” days. For ECM, use “fibrin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| B27 (-Insulin) | — | — |
| Activin A | — | — |
| BMP4 | — | — |
Ideally, “mesoderm” should be obtained at the end of culture.
Step 3: endothelial 1
day 3 ~ 5
culture “spheroid” human PSC in “EBM2” for “2” days. For ECM, use “fibrin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| B27 (-Insulin) | — | — |
| VEGF | — | — |
| EPO | — | — |
| TGFb1 | — | — |
Step 4: endothelial 2
day 5 ~ 7
culture “adherent” human PSC in “EGM2-MV” for “2” days. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| B27 | — | — |
| VEGF | — | — |
| SB431542 | — | — |
Ideally, “EC” should express “PECAM1”, “CDH5”, “vWF-8” at the end of culture.